Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 11626
Country/Region: Zambia
Year: 2014
Main Partner: Johns Hopkins University
Main Partner Program: JHPIEGO
Organizational Type: University
Funding Agency: USDOD
Total Funding: $0 Additional Pipeline Funding: $2,550,000

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Jhpiego will support ZDF to improve clinical prevention, care, and treatment services. The projects’ focus is to improve the quality of services, support sustainable training, supervision, mentorship and M&E systems to expand HIV/AIDS services. This project will contribute reducing the spread of HIV/AIDS in Zambia by building ZDF capacity to prevent infections and provide comprehensive care and treatment through 14 ZDF facilities in Eastern, Southern and Western provinces. This will be achieved via the following objectives:

1) Increase the clinical capability of ZDF providers to deliver comprehensive HIV/AIDS services;

2) Integrate HIV counseling and testing into palliative care services;

3) Strengthen services for diagnosis and management of STIs

; 4) Strengthen VMMC services at 6 ZDF facilities to reach 14,000 males above 15 years old; and

5) Strengthen health systems to improve human resource gaps through provision of financial and technical support for the DSHS.

These objectives will be accomplished through coordinated and integrated programming in: PMTCT to operationalize Option B+ at targeted ZDF; Male Circumcision to support sustained, targeted demand creation and outreach services; Adult Care and Support to ensure comprehensive provision of HIV services; Adult Treatment to improve quality of ART services; Pediatric Care and Support to ensure that appropriate care for HIV positive children is available; Pediatric Treatment to ensure early identification and initiation of ART among infants and children; TB/HIV to strengthen TB case finding among HIV positive individuals; and Health Systems Strengthening to build capacity within ZDF to manage a sustainable training system that produces qualified human resources for health.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D_TA By Age/Sex: 15+ Female 2015 1,969
C2.1.D_TA By Age/Sex: 15+ Male 2015 1,535
C2.1.D_TA By Age/Sex: <15 Female 2015 178
C2.1.D_TA By Age/Sex: <15 Male 2015 128
C2.1.D_TA By Age: 15+ 2015 3,504
C2.1.D_TA By Age: <15 2015 306
C2.1.D_TA By Sex: Female 2015 2,147
C2.1.D_TA By Sex: Male 2015 1,663
C2.1.D_TA Number of HIV-positive individuals receiving a minimum of one clinical service 2015 3,810
C2.1.D_TA Sum of Age disaggregates 2015 3,810
C2.1.D_TA Sum of Age/Sex disaggregates 2015 3,810
C2.1.D_TA Sum of Sex disaggregates 2015 3,810
CARE_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR supported sites providing clinical care services 2015 13
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 13
CARE_SITE Sum of Denominator Site Support Type disaggregates 2015 13
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 13
FPINT_SITE_DSD By site support type: Technical Assistance-only (TA): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 14
FPINT_SITE_DSD By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported HIV service delivery points 2015 14
FPINT_SITE_DSD Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 14
FPINT_SITE_DSD Service delivery type: Clinical 2015 14
FPINT_SITE_DSD Sum of Denominator Site Support Type disaggregates 2015 14
FPINT_SITE_DSD Sum of Numerator Site Support Type disaggregates 2015 14
FPINT_SITE_DSD Sum of Service Delivery Type disaggregates 2015 14
FPINT_SITE_DSD Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2015 14
HTC_TST_NGI Age/sex: 1-4 Male 2015 1,176
HTC_TST_NGI Age/sex: 10-14 Female 2015 1,063
HTC_TST_NGI Age/sex: 10-14 Male 2015 1,382
HTC_TST_NGI Age/sex: 15-19 Female 2015 1,954
HTC_TST_NGI Age/sex: 15-19 Male 2015 1,344
HTC_TST_NGI Age/sex: 20-24 Female 2015 440
HTC_TST_NGI Age/sex: 20-24 Male 2015 981
HTC_TST_NGI Age/sex: 25-49 Male 2015 9
HTC_TST_NGI Age/sex: 5-9 Female 2015 444
HTC_TST_NGI Age/sex: 5-9 Male 2015 2,208
HTC_TST_NGI Aggregated Age/sex: 15+ Female 2015 3,457
HTC_TST_NGI Aggregated Age/sex: 15+ Male 2015 3,716
HTC_TST_NGI Aggregated Age/sex: <15 Female 2015 444
HTC_TST_NGI Aggregated Age/sex: <15 Male 2015 3,384
HTC_TST_NGI By Test Result: Negative 2015 10,591
HTC_TST_NGI By Test Result: Positive 2015 410
HTC_TST_NGI Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 11,001
HTC_TST_NGI Sum of Age/Sex disaggregates 2015 11,001
HTC_TST_NGI Sum of Aggregated Age/Sex 15+ 2015 7,173
HTC_TST_NGI Sum of Aggregated Age/Sex <15 2015 3,828
HTC_TST_NGI Sum of Aggregated Age/Sex disaggregates 2015 11,001
HTC_TST_NGI Sum of Test Result disaggregates 2015 11,001
HTC_TST_TA Age/sex: 1-4 Male 2015 1,176
HTC_TST_TA Age/sex: 10-14 Female 2015 1,063
HTC_TST_TA Age/sex: 10-14 Male 2015 1,382
HTC_TST_TA Age/sex: 15-19 Female 2015 1,954
HTC_TST_TA Age/sex: 15-19 Male 2015 1,344
HTC_TST_TA Age/sex: 20-24 Female 2015 440
HTC_TST_TA Age/sex: 20-24 Male 2015 981
HTC_TST_TA Age/sex: 25-49 Male 2015 9
HTC_TST_TA Age/sex: 5-9 Female 2015 444
HTC_TST_TA Age/sex: 5-9 Male 2015 2,208
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 3,457
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 3,716
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 444
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 3,384
HTC_TST_TA By Test Result: Negative 2015 10,591
HTC_TST_TA By Test Result: Positive 2015 410
HTC_TST_TA Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 11,001
HTC_TST_TA Sum of Age/Sex disaggregates 2015 11,001
HTC_TST_TA Sum of Aggregated Age/Sex 15+ 2015 7,173
HTC_TST_TA Sum of Aggregated Age/Sex <15 2015 3,828
HTC_TST_TA Sum of Aggregated Age/Sex disaggregates 2015 11,001
HTC_TST_TA Sum of Test Result disaggregates 2015 11,001
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 210
PMTCT_ARV_NGI Maternal triple ARV prophylaxis (provided with the intention to stop at the end of the breastfeeding period) 2015 104
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 376
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 314
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 75
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 135
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 210
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 314
PMTCT_ARV_TA Life-long ART (including Option B+) 2015 314
PMTCT_ARV_TA Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 376
PMTCT_ARV_TA Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 314
PMTCT_ARV_TA Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 127
PMTCT_ARV_TA Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 187
PMTCT_ARV_TA Sum of New and Current disaggregates 2015 314
PMTCT_ARV_TA Sum of Regimen Type disaggregates 2015 314
PMTCT_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 12
PMTCT_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 13
PMTCT_SITE Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 12
PMTCT_SITE Sum of Denominator Support Type disaggregates 2015 13
PMTCT_SITE Sum of Numerator Support Type disaggregates 2015 12
PMTCT_SITE Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 13
PMTCT_STAT_NGI By: Known positives at entry 2015 109
PMTCT_STAT_NGI By: Number of new positives identified 2015 267
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 3,130
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 3,130
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 376
PMTCT_STAT_TA By: Known positives at entry 2015 109
PMTCT_STAT_TA By: Number of new positives identified 2015 267
PMTCT_STAT_TA Number of new ANC and L&D clients 2015 3,130
PMTCT_STAT_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 3,130
PMTCT_STAT_TA Sum of Positives Status disaggregates 2015 376
QI_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC 2015 15
QI_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 14
QI_SITE By site support type: Technical Assistance-only (TA): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 15
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 14
QI_SITE Sum of Denominator Site Support Type disaggregates 2015 30
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 14
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 14
SITE_SUPP By program area/support type: Care and Support Technical Assistance-only (TA) 2015 13
SITE_SUPP By program area/support type: HTC Technical Assistance-only (TA) 2015 15
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Technical Assistance-only (TA) 2015 13
SITE_SUPP By program area/support type: PMTCT Technical Assistance-only (TA) 2015 13
SITE_SUPP By program area/support type: TB/HIV Technical Assistance-only (TA) 2015 13
SITE_SUPP By program area/support type: Treatment Technical Assistance-only (TA) 2015 8
SITE_SUPP By program area/support type: VMMC Direct Service Delivery (DSD) 2015 6
SITE_SUPP Number of unique sites supported by PEPFAR 2015 15
SI_ME Existence of a national HIV/AIDS M&E system based on the UNAIDS 12 components model 2015 14
TX_CURR_NGI Age/Sex: 1-4 Female 2015 10
TX_CURR_NGI Age/Sex: 15+ Female 2015 2,500
TX_CURR_NGI Age/Sex: 15+ Male 2015 2,000
TX_CURR_NGI Age/Sex: 5-14 Female 2015 169
TX_CURR_NGI Age/Sex: 5-14 Male 2015 116
TX_CURR_NGI Age/Sex: <1 Female 2015 2
TX_CURR_NGI Age/Sex: <1 Male 2015 6
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 2,500
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 2,000
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 2
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 6
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 181
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 122
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 4,803
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 4,803
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 4,500
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 303
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 4,803
TX_CURR_TA Age/Sex: 1-4 Female 2015 10
TX_CURR_TA Age/Sex: 15+ Female 2015 2,500
TX_CURR_TA Age/Sex: 15+ Male 2015 2,000
TX_CURR_TA Age/Sex: 5-14 Female 2015 169
TX_CURR_TA Age/Sex: 5-14 Male 2015 116
TX_CURR_TA Age/Sex: <1 Female 2015 2
TX_CURR_TA Age/Sex: <1 Male 2015 6
TX_CURR_TA Aggregated Age/Sex: 15+ Female 2015 2,500
TX_CURR_TA Aggregated Age/Sex: 15+ Male 2015 2,000
TX_CURR_TA Aggregated Age/Sex: <1 Female 2015 2
TX_CURR_TA Aggregated Age/Sex: <1 Male 2015 6
TX_CURR_TA Aggregated Age/Sex: <15 Female 2015 181
TX_CURR_TA Aggregated Age/Sex: <15 Male 2015 122
TX_CURR_TA Number of adults and children receiving antiretroviral therapy (ART) 2015 4,803
TX_CURR_TA Sum of Age/Sex disaggregations 2015 303
TX_CURR_TA Sum of Aggregated Age/Sex 15+ 2015 4,500
TX_CURR_TA Sum of Aggregated Age/Sex <15 2015 303
TX_CURR_TA Sum of Aggregated Age/Sex disaggregates 2015 4,803
TX_DIST Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District 2015 7
TX_DIST Total number of PEPFAR supported District Health Offices 2015 7
TX_SITE By support type: Technical Assistance (TA-only): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 8
TX_SITE By support type: Technical Assistance (TA-only): Total number of PEPFAR-supported ART sites 2015 8
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 8
TX_SITE Sum of Denominator Site Support Type disaggregates 2015 8
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 8
TX_SITE Total number of PEPFAR-supported ART sites 2015 8
VMMC_AE_DSD By AE Type: Number of VMMC clients with one or more moderate or severe surgical post-operative AE(s) 2015 34
VMMC_AE_DSD Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2015 68
VMMC_AE_DSD Sub-Disag: By Surgical post-operative AE(s) by maximum severity category: Number of clients with one or more moderate surgical post-operative AE(s), but no severe surgical post-operative AE(s) 2015 30
VMMC_AE_DSD Sub-Disag: By Surgical post-operative AE(s) by maximum severity category: Number of clients with one or more severe surgical intra-operative AE(s) 2015 4
VMMC_CIRC_DSD By Age: 10-14 2015 2,171
VMMC_CIRC_DSD By Age: 15-19 2015 1,572
VMMC_CIRC_DSD By Age: 20-24 2015 1,607
VMMC_CIRC_DSD By Age: 25-49 2015 1,633
VMMC_CIRC_DSD By Age: 50+ 2015 18
VMMC_CIRC_DSD By circumcision technique: Surgical VMMC 2015 7,001
VMMC_CIRC_DSD By follow-up status: Number of surgically circumcised clients who did NOT return for follow-up care within 14 days of circumcision surgery 2015 1,400
VMMC_CIRC_DSD By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2015 5,600
VMMC_CIRC_DSD By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2015 1,363
VMMC_CIRC_DSD By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2015 5,589
VMMC_CIRC_DSD By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2015 49
VMMC_CIRC_DSD Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2015 7,001
VMMC_CIRC_DSD Sum of age disaggregates 2015 7,001
Key Issues Identified in Mechanism
Military Populations
Mobile Populations
Safe Motherhood
Tuberculosis
Family Planning